Personalizing Medical Cannabis Treatment
A NEW APPROACH
WATCH HOW WE ARE PERSONALIZING MEDICAL CANNABIS TREATMENT
Our proprietary technology measures metabolic biomarkers to quantify how each person responds to cannabis, accounting for the genetic makeup, environmental and lifestyle factors of each individual.
Our bioinformatics platform guides you to the best-fit available medical cannabis treatment, optimizing products, dosage and consumption methods to meet your wellness needs and improve quality of life.
AREA OF FOCUS
Initially we are focusing on Autism, with plans to expand to anxiety, pain, neurodegenerative diseases and nausea. Our platform is designed to work for virtually any medical condition treatable by cannabis.
ASD PILOT STUDY ANNOUNCEMENT
Cannformatics Publishes Third Paper Revealing Progress Towards Personalizing Medical Cannabis Treatment for ASD and other Neurological and Neuropyschiatric Disorders in Nature's Scientific Reports.
To deliver predictable and repeatable science-based medical cannabis outcomes to improve health and quality of life.
NEW STANDARDS FOR MEDICAL CANNABIS TREATMENT
We are committed to being an unbiased partner to the medical cannabis community, providing medical and scientific data to improve wellness outcomes, reduce stigma and inspire innovation across the industry.
Health Care Providers (HCP)
We partner with HCPs who recommend cannabis to their patients. Our bioinformatics platform will help HCPs understand the impact of medical cannabis treatment on each individual. If you would like to know more, please contact us.
The privacy and confidentiality of your personal and medical information is important to us. Cannformatics is HIPAA-compliant. We comply with all Federal, State and local privacy and security regulations.
Cannformatics does not diagnose medical conditions, prescribe medical cannabis or recommend cannabis as a replacement for medical treatment.